Vimarsana
Biggest News Aggregation in the World

Page 18 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Liquid Biopsy Market is expected to grow at a CAGR of 20.9 % through the forecast period according to a new research report - Vimarsana News

Liquid Biopsy Market is expected to grow at a CAGR of 20.9 % through the forecast period according to a new research report

Liquid Biopsy Market: Global Industry Analysis and Forecast (2023-2029)

Genetic Testing Market to Reach $28.24 Billion by 2030 - Vimarsana News

Genetic Testing Market to Reach $28.24 Billion by 2030

Genetic Testing Market to Reach $28.24 Billion by 2030

Myriad Genetics Announces Pricing of Upsized Offering of - Vimarsana News

Myriad Genetics Announces Pricing of Upsized Offering of

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing...

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock - Myriad Genetics (NASDAQ:MYGN) - Vimarsana News

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock - Myriad Genetics (NASDAQ:MYGN)

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) (the "Company" or "Myriad Genetics"), a leader in genetic testing and precision medicine, today announced the pricing of an upsized

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Acutus Medical (NASDAQ:AFIB), Affirm Holdings (NASDAQ:AFRM) - Vimarsana News

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Acutus Medical (NASDAQ:AFIB), Affirm Holdings (NASDAQ:AFRM)

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.